Results 61 to 70 of about 23,012 (218)
Clinical progress note: Varicella Zoster
Abstract Varicella Zoster virus (VZV) is the etiologic agent responsible for varicella and herpes zoster (shingles). Nonimmune children and adults acutely infected with VZV typically experience a vesicular and pruritic rash that progresses from the face and trunk and generalizes to the extremities, accompanied by an oral enanthem along with symptoms of
Sirey Zhang, Adam L. Hersh, T. W. Jones
wiley +1 more source
Resurgence of Mumps in India: A Call to Reintroduce MMR into the Immunization Program
The recent rise in mumps outbreaks across several Indian states exposes a critical gap in the national immunization framework specifically, the absence of mumps vaccination in the Universal Immunization Programme (UIP).
Lalithambigai Chellamuthu, Anlin Jenisha
doaj +1 more source
This phase III clinical trial was conducted to evaluate the immunogenicity and safety of the single-dose and multi-dose formulations of a novel MMR vaccine (live, freeze-dried) developed by M/s Cadila Healthcare Limited, India (Cadila MMR vaccine ...
Ashwani Sood +10 more
doaj +1 more source
Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
To analyze the epidemiology of a nationwide mumps epidemic in the Netherlands, we reviewed 1,557 notified mumps cases in persons who had disease onset during September 1, 2009–August 31, 2012. Seasonality peaked in spring and autumn.
Jussi Sane +6 more
doaj +1 more source
Should Mumps Be Higher Up on the Public Health Agenda in India? A Concern for Global Health Security
Mumps is a public health problem on a global scale caused by mumps virus, a member of family paramyxoviridae. An effective form of vaccination exists and is incorporated into routine immunization schedules in over 100 countries, usually in the form of ...
Syed Manzoor Kadri +4 more
doaj +1 more source
Serological evaluation of 52 children immunized with the combined measles, mumps and rubella vaccine
Fifty-two of 298 children vaccinated with the measles-mumps-rubella (MMR) vaccine at around the age of 16 months were evaluated for antibody titres against measles, mumps, and rubella.
B Topal, G Kanra, M Ceyhan
doaj
Background and objectives: Plane wart treatment is challenging; modalities such as cauterization and cryotherapy having a great probability to recur, as well as the risk of scarring, discomfort, and expensive costs.
Banu Muhammed Jaza Noori +1 more
doaj +1 more source
Mumps outbreak in an unimmunized population - Luanshya District, Copperbelt Province, Zambia, 2015
INTRODUCTION: Mumps is a vaccine-preventable viral disease that may cause deafness, orchitis, encephalitis or death. However, mumps vaccine is not included in Zambia's Expanded Program for Immunization.
Ernest Kateule +9 more
doaj +1 more source
Safety analysis of a live attenuated mumps vaccine in healthy adolescents in China: A phase 4, observational, open-label trial. [PDF]
Hu W +7 more
europepmc +1 more source

